Work

Serum BAFF Level Informs Risk of Hypogammaglobulinemia in Patients with Multiple Sclerosis on Ocrelizumab (P5-1.011)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000211957

Authors: Anastasia Chumakova, Gaby Thai, Michael Demetriou, Victoria Fleming, Supna Saxena, Michael Sy

Institution: University of California, Irvine

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409226232

FWCI:

Cites:

Cited by:

Related to: 10